FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 359:1624-1625 October 9, 2008 Number 15 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Gueugniaud, P.-Y. PubMed Citation

To the Editor: Gueugniaud et al. (July 3 issue)¹ report that administering the combination of vasopressin and epinephrine, as compared with epinephrine alone, during advanced cardiac life support for out-of-hospital cardiac arrest does not improve outcome. The results of this study, however, are not surprising, considering that the average time from collapse to the arrival of advanced cardiac life support (downtime) was 16.3 minutes in each group and that only 9% of the patients in each group had ventricular fibrillation and thus a greater chance of survival than the patients with pulseless electrical activity or asystole. Studies have shown that . . . [Full Text of this Article]

This article has been cited by other articles:

• Olasveengen, T. M., Sunde, K., Brunborg, C., Thowsen, J., Steen, P. A., Wik, L. (2009). Intravenous Drug Administration During Out-of-Hospital Cardiac Arrest: A Randomized Trial. JAMA 302: 2222-2229 [Abstract] [Full Text]